Basic Information
Micronoma is the first cancer detection company to use liquid biopsy technology to detect and predict cancer by querying microbial signals with clinical-grade accuracy in the early stages of disease. Micronoma can detect and differentiate microbes in the blood and predict whether a patient is cancer-free or has a specific type of cancer. A liquid biopsy is a test performed on a blood sample to look for circulating tumor cells (CTCs) or DNA that have shed from a tumor. Liquid biopsies may help in the early detection of cancer.
Micronoma Inc.
SanDiego,California,United States of America
less than 15 people
June 01, 2019
info@micronoma.com

